These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 30797091)

  • 1. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of bla
    Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
    J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
    Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
    Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI-TOF MS as a Tool To Detect a Nosocomial Outbreak of Extended-Spectrum-β-Lactamase- and ArmA Methyltransferase-Producing Enterobacter cloacae Clinical Isolates in Algeria.
    Khennouchi NC; Loucif L; Boutefnouchet N; Allag H; Rolain JM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6477-83. PubMed ID: 26239991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals.
    Abdalhamid B; Albunayan S; Shaikh A; Elhadi N; Aljindan R
    J Med Microbiol; 2017 Sep; 66(9):1286-1290. PubMed ID: 28820112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.
    Shaaban M; Elshaer SL; Abd El-Rahman OA
    BMC Microbiol; 2022 Oct; 22(1):247. PubMed ID: 36221063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
    ElTaweel M; Said HS; Barwa R
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of extended-spectrum β-lactamase- and plasmid AmpC-producing Escherichia coli strains isolated from broilers in Béjaïa, Algeria.
    Belmahdi M; Bakour S; Al Bayssari C; Touati A; Rolain JM
    J Glob Antimicrob Resist; 2016 Sep; 6():108-112. PubMed ID: 27530851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.
    Robin F; Beyrouthy R; Bonacorsi S; Aissa N; Bret L; Brieu N; Cattoir V; Chapuis A; Chardon H; Degand N; Doucet-Populaire F; Dubois V; Fortineau N; Grillon A; Lanotte P; Leyssene D; Patry I; Podglajen I; Recule C; Ros A; Colomb-Cotinat M; Ponties V; Ploy MC; Bonnet R
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar.
    Rakotonirina HC; Garin B; Randrianirina F; Richard V; Talarmin A; Arlet G
    BMC Microbiol; 2013 Apr; 13():85. PubMed ID: 23594374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria.
    Yousfi M; Touati A; Muggeo A; Mira B; Asma B; Brasme L; Guillard T; de Champs C
    J Glob Antimicrob Resist; 2018 Mar; 12():187-191. PubMed ID: 29042339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of a Multidrug-Resistant VIM-1- and CMY-99-Producing Proteus mirabilis Clone in Bulgaria.
    Markovska R; Schneider I; Keuleyan E; Ivanova D; Lesseva M; Stoeva T; Sredkova M; Bauernfeind A; Mitov I
    Microb Drug Resist; 2017 Apr; 23(3):345-350. PubMed ID: 27341161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Hodžić D; Bedenić B
    Med Glas (Zenica); 2016 Aug; 13(2):103-12. PubMed ID: 27313108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.